Acetylcholinesterase Protein Level Is Preserved in the Alzheimer's Brain

• DOI: 10.1007/s12031-013-0183-5
• Publication Date: 2013-12-06T12:30:15Z
• Authors: María-Letizia Cam...; María-Salud Garcí...; Lidia Blazquez-Ll...; Wilson K. W. Luk; Karl Tsim; Javier Sáez-Valero
• Keywords: Aged, 80 and over; Male; 0303 health sciences; Beta-Amyloid; Brain; 612; Alzheimer's disease; Middle Aged; 3. Good health; 03 medical and health sciences; Alzheimer Disease; Case-Control Studies; Acetylcholinesterase; Presenilin-1; Humans; Female; β-Amyloid; beta-Amyloid; Aged

Acetylcholinesterase (AChE) is a key enzyme in the cholinergic nervous system and is one of the most studied proteins in the field of Alzheimer's disease (AD). Moreover, alternative functions of AChE unrelated with the hydrolysis of acetylcholine are suspected. Until now, the majority of investigations on AChE in AD pathology have been focused on the determination of its enzymatic activity level, which is depleted in the AD brain. Despite this overall decrease, AChE activity increases at the vicinity of the two hallmarks of AD, the amyloid plaques and the neurofibrillary tangles (NFT). In fact, AChE may directly interact with Aβ in a manner that increases the deposition of Aβ to form plaques. In the context of protein-protein interactions, we have recently reported that AChE can interact with presenilin-1, the catalytic component of γ-secretase, influencing its expression level and also its activity. However, the alteration of AChE protein in the AD brain has not been determined. Here, we demonstrated by Western blotting and immunohistochemistry that a prominent pool of enzymatically inactive AChE protein existed in the AD brain. The potential significance of these unexpected levels of inactive AChE protein in the AD brain was discussed, especially in the context of protein-protein interactions with β-amyloid and presenilin-1.